Gemtaz Infusmart 1.2g Injection
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Gemcitabine (1200mg)
Overview Gemtaz Infusmart 1.2g Injection
Gemtaz Infusmart 1.2g Injection is indicated for the management of several cancers, including non-small cell lung, breast, pancreatic, bladder, and ovarian cancers. Administration is strictly via intravenous injection by a healthcare professional. Dosage and frequency are determined by your physician based on your individual needs and may vary. Precise adherence to your doctor's prescribed regimen is crucial. Improper use or overdose can lead to severe adverse events. Therapeutic effects may not be apparent for weeks or months; discontinuation should only occur under medical supervision. Commonly reported side effects include nausea, emesis, anorexia, alopecia, and thrombocytopenia. This medication can suppress blood cell production, increasing infection risk. Regular blood tests monitoring blood cell counts, along with cardiac, hepatic, and uric acid levels, are essential. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, and all other medications, including antibiotics, to your physician. Significant drug interactions are possible. This injection is contraindicated during pregnancy and lactation. Reliable contraception is strongly advised for both partners throughout the treatment period.
Uses of Gemtaz Infusmart 1.2g Injection
Lung cancer (non-small cell), breast cancer, pancreatic cancer, bladder cancer, and ovarian cancer.
Major Benefits of Gemtaz Infusmart 1.2g Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Gemtaz Infusmart 1.2g Injection:
- Nausea
- Vomiting
- Loss of appetite
- Hair loss
- Low blood platelets
- Allergic reaction
- Breathlessness
- Decreased white blood cell count
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Flu-like symptoms
- Blood in urine
- Skin rash
- Protein in urine
How to use Gemtaz Infusmart 1.2g Injection:
This medication will be administered by your physician or their registered nurse. Self-medication is strictly prohibited.
How Gemtaz Infusmart 1.2g Injection works:
Gemtaz Infusmart 1.2g Injection halts cancer cell proliferation by disrupting their DNA and RNA synthesis. This is achieved by replacing essential components needed for their replication, effectively inhibiting further growth and division.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Gemtaz Infusmart 1.2g Injection and alcohol may result in heightened somnolence.
PregnancyCONSULT YOUR DOCTOR
Administering Gemtaz Infusmart 1.2g Injection during pregnancy poses a confirmed risk to the fetus. Its use should be restricted to life-threatening emergencies where potential benefits clearly outweigh the known hazards, and only under a physician's direct supervision. Always seek medical advice before use.
Breast feedingUNSAFE
Administering Gemtaz Infusmart 1.2g Injection to breastfeeding individuals is contraindicated. Evidence indicates potential infant harm from the medication.
DrivingUNSAFE
Administering Gemtaz Infusmart 1.2g Injection could reduce vigilance, impair vision, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Gemtaz Infusmart 1.2g Injection's use in individuals with renal impairment. Physician consultation is necessary. Pre-treatment and post-treatment kidney function assessments are recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Gemtaz Infusmart 1.2g Injection to individuals with hepatic impairment. Seek medical advice from your physician.
What if you forget to take Gemtaz Infusmart 1.2g Injection :
NA
Facts to Know About Gemtaz Infusmart 1.2g Injection
| Label | Value |
|---|---|
| Chemical Type | Cytosine Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Metabolic inhibitors |
3,018 People bought this recently